⟳ Репост от Timothy Pratt
Even before USAID was dissolved, US pharmaceutical companies like Gilead had left much of Latin America out of generic agreements that make long-acting PReP affordable. They justify this by claiming that countries like Brazil, Colombia and Mexico are “high middle income.”